Download Docs
Export

Altered ercc1 expression correlates with responses to cisplatin (ddp) and gemcitabine efficacy non-small-cell lung cancer (nsclc) patients

60/250,470 | U.S. Patent Application

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Date # Transaction
More information is available to registered Docket Alarm users.